Costa News Spain Breaking News | English News in Spain.
IT has been hailed as a ‘miracle’, helping those most in need to shift excess timber quicker than ever.
The long-term effectiveness of weight-loss medications such as Ozempic, Monjauro or other similar drugs may not be what was initially believed. This is the conclusion of a landmark research.
Academics at the University of Oxford have found that people who stop taking the injections after a period of time gain weight faster than anyone else.
People who stop doing weight loss jobs will usually regain the original weight lost in less than two years.
Dr Sam West, the postdoctoral research fellow at Oxford University who led the study said, “These medications are transforming obesity treatments and can achieve significant weight loss.”
“However, our research shows that people tend to regain weight rapidly after stopping – faster than we see with behavioural programmes.”
He added: “This isn’t a failing of the medicines – it reflects the nature of obesity as a chronic, relapsing condition. This is a warning against short-term usage without a comprehensive approach to weight management over the long term. It also highlights the importance primary prevention.
Researchers monitored the weight-loss journeys of 9341 participants for an average period of 32 weeks after they stopped taking their drugs.
Weight loss was averaged to 0.4kg a month. Participants returned to their pre-jab body weight on average 1.7 years after stopping the medication.
READ MORE: Weight loss hunters looking to buy Ozempic at a discount are placing Gibraltar in the center of a new illegal market with Spain
Weight loss medications are effective for a lot of people. They can lose up to 8.3kg in the first year, but then gain back 4.8kg.
It is four times as fast as traditional weight-loss programs that are based on diet or exercise.
Studies have shown that weight loss jobs can improve a patient’s overall health by improving cardiometabolic health markers like blood pressure or cholesterol.
But within 1.4-years of ceasing treatment, they were back to their previous level.
“Weight loss drugs can be effective tools for managing weight and type 2 diabetes risk – but this research reinforces that they are not a quick fix,” said Dr Faye Riley, research communications lead at Diabetes UK.
The medication should be prescribed with tailored support to help people maintain their weight loss as long as they can after stopping the medication.
Weight-loss drugs were developed originally as a diabetes treatment. They work by simulating the GLP-1 (glucagon-like peptide 1) hormone, which makes people feel fuller after eating.
Click here to read the latest Spain News at The Olive Press.
